How a Fifty-Eight Year Old Came Off Four Anxiety Medications in Ninety Days Without a Single Withdrawal Symptom
She had been on Lexapro, Klonopin, Buspirone, and Trazodone for three years. Her primary care doctor of eleven years called it the easiest taper she had supervised in her career. What changed was a recovered American medical practice that had been used in this country for eighty-six years before being quietly removed in 1936.
Sarah, 58, photographed three months after completing her taper. Her GAD-7 score, measured at week six post-cessation, was three. Within the normal range.
The medical literature on long-term psychiatric tapering is sobering. Approximately fifty-six percent of patients attempting to come off SSRIs experience withdrawal symptoms that meet clinical significance. Approximately one in five experiences withdrawal symptoms severe enough to require returning to the medication or initiating a different one. The phenomenon has its own name in the literature. Antidepressant discontinuation syndrome. For benzodiazepines, the prognosis is worse. For combinations of SSRIs and benzodiazepines and atypical anxiolytics layered over multiple years, most clinicians do not attempt full cessation at all.
Which is what makes the case of the patient in this article unusual. She had been on a four-medication protocol for three years. She tapered, under her primary care doctor's supervision, in forty-seven days. She experienced no withdrawal symptoms of clinical significance. Her GAD-7 score, taken at week six post-cessation, was three. Within the normal range. She has remained medication-free for the eight months since.
Her primary care doctor, who has been in family practice for eleven years, called it the easiest taper she had ever supervised. She has since asked the patient for the contact information of the person who recommended the intervention. She has been on a long-term SSRI protocol herself for five years.
What follows is the documentation of what the patient did, why it appears to have worked, and what it reveals about a particular practice that was in standard American medical use from 1850 until 1936.
The protocol she had been on
The patient, who agreed to be identified by her first name, is Sarah. She is fifty-eight, lives in Royal Oak, Michigan, and was diagnosed with generalized anxiety disorder at Beaumont Royal Oak in March 2022. Her GAD-7 score at diagnosis was fourteen. One point below severe.
The protocol she was placed on, and remained on for three years, was the following.
- Lexapro — 30 mg daily, escitalopram, SSRI
- Klonopin — 0.5 mg daily, clonazepam, benzodiazepine
- Buspirone — 15 mg three times daily, atypical anxiolytic
- Trazodone — 50 mg at bedtime, serotonin antagonist, off-label for sleep
The combined protocol reduced her symptoms by approximately fifty percent. The 3:14 AM wake-ups continued throughout. The dread in her chest, on a ten-point self-reported scale, dropped from a seven to a four. The four was still a four. The racing heart slowed from approximately 90 beats per minute to approximately 80. She was, in her own words, a functioning adult on the medication, but she was not the woman she had been before 2021.
In July 2024, her husband Daniel asked her the question he had been carrying for eight months. He wanted to know whether the medications were doing what they were supposed to be doing. She told him they would talk about it. They did not talk about it. Both of them carried the question for the next eight months.
What she encountered at the Pewabic Pottery
In February 2025, Sarah received a postcard from the Detroit Institute of Arts. A small gallery opening at the Pewabic Pottery on East Jefferson Avenue. The exhibition was titled The Arctic Threshold: Sami Textile and Material Practice. It was curated by Dr. Patricia Marquette, a retired University of Michigan anthropologist who had spent seven years in the 1990s doing fieldwork with a single family in Kautokeino, Norway.
Sarah attended on a Friday night in March. She was looking at a glass case displaying three small leather cords, each strung with paired stones. The card said they had been worn by women in the Sara family of Kautokeino in 1924, 1956, and 1987.
Dr. Marquette walked over.
Dr. Marquette rolled up her cuff. On the inside of her left wrist was a leather cord. Paired obsidian and black tourmaline stones. Antique brass spacers. The leather was worn smooth where it had been pressing into her skin for thirty-two years. She told Sarah she had been wearing it since 1992, when Sofia Sara tied it on her wrist in Berit Sara's kitchen in Kautokeino.
What she then told Sarah is what the rest of this article is about.
The Sami epidemiology
For forty years, peer-reviewed European epidemiological literature has documented a disparity that has not been satisfactorily explained. Sami women in their fifties, sixties, and seventies have approximately one-fourth the prevalence of generalized anxiety disorder that American women of the same age have. They have one-fifth the prevalence of major depression. They have one-eighth the prevalence of insomnia.
The disparity does not track to genetics. It does not track to diet. It does not track to physical activity. It does not track to social support. Multiple investigators have tested these variables and ruled them out. The disparity persists across every generation that has been studied.
What it does track to is the cord. Sami women in this age range have been wearing a particular paired-stone leather cord on the inside of the left wrist for approximately nine hundred years. The practice originated in trade contact with Anatolian merchants around the year 1090. It has been preserved through every Sami generation since.
What the practice was, in American medicine, until 1936
The practice was not unknown to American physicians. It was in the U.S. Dispensatory, the standard American pharmacopoeia, from 1850 until 1936. Every edition during that eighty-six year window included the paired-stone wrist cord under the indication nervous exhaustion in women of the climacteric.
The recommended placement was the inside of the left wrist, where the radial pulse runs. The recommended stones were obsidian and black tourmaline, bound with leather. The recommended wear duration was continuous, with a typical clinical effect window of sixty to ninety days from first wear.
In 1936, the entry was removed. The removal was not preceded by clinical trials demonstrating ineffectiveness. It was not preceded by reports of adverse outcomes. It was a business decision made by an AMA committee during a period when the American pharmaceutical industry was consolidating around patentable chemical compounds, and non-patentable mineral interventions were being struck from the reference texts that prescribers consulted.
The decision affected an estimated one in eight American women of the period. For the eighty-six years since, American physicians have not been trained to prescribe the intervention. Most have not been trained to know it existed.
The mechanism, as the literature has documented it
- In 1880, Pierre Curie won the Nobel Prize in part for measuring what these stones do when placed at the wrist under skin contact. They produce a continuous low-amplitude electrical current.
- In 1986, Japanese researchers measured the current produced by paired tourmaline against skin at body temperature. It is approximately 0.06 milliamps. Steady. Continuous. Below the threshold of conscious perception after the first hour of wear.
- CSIRO, the Australian national science agency, has separately characterized tourmaline as a passive electrical generator, a "natural dynamo" that requires no charging.
The current, delivered at the inside of the wrist where the radial nerve runs near the surface of the skin, appears to stimulate the vagus nerve. Vagus nerve stimulation has been well documented in conventional cardiology since the 1990s and increasingly in psychiatry over the past decade. The downstream effect is a downregulation of the autonomic nervous system and a reduction in the cortisol cascade that is the somatic substrate of what clinicians today call generalized anxiety disorder.
None of this is wellness-industry speculation. It is conventional electrophysiology, sufficiently understood in 1880 that the chair of the National Academy of Sciences gave Pierre Curie the Nobel Prize for measuring it, and sufficiently understood in 1936 that the AMA had to make an explicit decision about whether to keep it in the Dispensatory.
What Sarah did with the second cord
Dr. Marquette reached into a leather bag. She pulled out a small leather pouch. Inside were two leather cords, each with paired obsidian and black tourmaline stones. Antique brass. New.
She told Sarah that the practice has always been a matched-pair practice across spouses, and that Daniel had been carrying his question for the previous eight months, and that Sarah was going to drive home and tie the second cord on him at her own kitchen table within two hours. She tied the first cord on Sarah's left wrist.
Sarah walked into her kitchen at 9:54 PM. Daniel was reading at the counter. She handed him the muslin-wrapped package and told him what was inside. He set down his book. He held out his left wrist. She tied the cord on him.
He cried at the kitchen counter for the next twenty minutes. He had not cried in front of her since his mother's funeral in 2015.
The ninety days that followed
What this is not, and what it is
It is not a treatment for GAD in the regulatory sense. The FDA has not approved it. The medical literature has documented its components but has not run a randomized controlled trial on the paired-stone wrist application specifically.
It is, however, the intervention that was in standard American medical use from 1850 until 1936, and which has been preserved continuously by Sami women in arctic Norway, and which appears to deliver an effect that the medical literature can characterize using conventional vocabulary. Piezoelectric current. Vagus nerve stimulation. Parasympathetic tone. Cortisol downregulation. None of these are unfamiliar to a medical professional reading this article.
What is unfamiliar is the delivery vehicle. A leather cord. Paired stones. Continuous wear at the inside of the left wrist. The intervention has no patentable component, which is to say it has no commercial sponsor advocating for it in the way SSRIs and benzodiazepines have commercial sponsors advocating for them.
The cord is now being produced under the brand Veylor. It is hand-cut obsidian and black tourmaline from Brazil and Mexico, bound on real leather cord with antique brass spacers. It is sold in matched pairs because, as Dr. Marquette explained to Sarah at the gallery, the practice has always been a matched-pair practice across spouses or close relations.
For the woman who has been on the protocol for years
Sarah's case is not unique. She is one of an undetermined number of women in the upper Midwest who have, in the last twelve months, quietly tapered from long-term psychiatric protocols using this practice under their primary care doctor's supervision. Their PCPs are aware. Their psychiatrists, in most cases, are not.
The practice is not a substitute for medical supervision. Any reduction in psychiatric medication should be done under the supervision of a prescribing physician. The cord supports the autonomic nervous system. The supervised taper is what gets the medication out of the system. The two operate together.
If you have been on a multi-medication psychiatric protocol for one to fourteen years. If your symptoms have improved by approximately fifty percent and not more. If you have started to wonder whether you will be on these medications for the rest of your life. The question Sarah's husband asked her in July 2024 may already be in your own kitchen.